Relay Therapeutics Hits Day High with 9.62% Surge in Stock Price

Relay Therapeutics, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant uptick in its stock performance today, gaining 9.62% as of October 15, 2025. The stock reached an intraday high of USD 6.62, marking a notable achievement in its trading activity.
In terms of performance metrics, Relay Therapeutics has outperformed the S&P 500 over various time frames. Over the past week, the stock rose by 8.18%, while the S&P 500 declined by 1.05%. The one-month performance shows an impressive increase of 62.81% for Relay, compared to a modest 0.91% gain for the broader market. Year-to-date, the stock has surged by 60.44%, significantly outpacing the S&P 500's 12.97% increase.

Despite these recent gains, the company has faced challenges over the longer term, with a three-year performance decline of 66.12% and a five-year drop of 82.38%. Financial indicators reveal a negative EBITDA and a return on equity of -46.80%, highlighting ongoing financial pressures. As Relay Therapeutics continues to navigate its market position, today's performance reflects a moment of resilience amid broader industry challenges.